CoverorDie

Squeeze Report — October 9, 2026

The tape is crowded with high-short-interest biotechs, but the fuel is mostly cheap and the options market has already pre-paid for the move. The more interesting setups are the event-driven consumer and industrial names where a real catalyst—earnings, a sale closing, or a strategic stake—could force actual covering.

15 ranked0 hot (≥80)15 squeezable (≥73)

Today's top short-squeeze candidates

  1. #1TNGXTango Therapeutics, Inc.79

    The raw #1 squeeze score is real, but three straight SI trims and zero borrow pressure make the ESMO catalyst the whole trade.

    SI 39%DTC 18.8$22.57-3% 20dHealthcare
  2. #2SYMSymbotic Inc. Class A Common S79

    A high short interest and fresh Buy rating are undercut by 90% Walmart concentration and an Up-C share overhang.

    SI 34%DTC 11.4$42.06+2% 20dIndustrials
  3. #3ABSIAbsci Corporation Common Stock78

    14.4 days to cover is the headline, but borrow at 0.42% with 2.2M shares available means no one is being forced.

    SI 25%DTC 14.4$8.94+8% 20dHealthcare
  4. #4BEAMBeam Therapeutics Inc. Common78

    29% of float sold short · 12.6 days to cover · +1% over 20 days · options pricing in the 90th percentile (crowded)

    SI 29%DTC 12.6$24.60+1% 20dHealthcare
  5. #5NTLAIntellia Therapeutics, Inc. Co78

    A 94th-percentile IV despite a 4% absolute level means any good news into Nov 5 earnings is likely to fade.

    SI 35%DTC 14.1$12.60+6% 20dHealthcare
  6. #6GLOBGLOBANT S.A.77

    Short interest rose 39.5% and days-to-cover exceed 10, but a guidance cut, class action, and put wall make this a tactical bounce at best.

    SI 29%DTC 10.7$37.05+1% 20dTechnology
  7. #7BSYBentley Systems, Incorporated76

    15% of float sold short · 8.0 days to cover · +12% over 20 days

    SI 15%DTC 8.0$34.82+12% 20dTechnology
  8. #8PRCHPorch Group, Inc. Common Stock76

    20% of float sold short · 12.9 days to cover · +8% over 20 days

    SI 20%DTC 12.9$17.53+8% 20dFinancial Services
  9. #9REPLReplimune Group, Inc. Common S75

    The FDA overhang is gone, but cheap options and a 16.6% biotech base rate make this a tactical bounce, not a conviction squeeze.

    SI 29%DTC 11.1$13.04-2% 20dHealthcare
  10. #10TDCTERADATA CORPORATION75

    18% of float sold short · 8.3 days to cover · +11% over 20 days

    SI 18%DTC 8.3$30.29+11% 20dTechnology
  11. #11PGENPrecigen, Inc. Common Stock75

    27% of float sold short · 16.3 days to cover · +14% over 20 days

    SI 27%DTC 16.3$7.60+14% 20dHealthcare
  12. #12OMEROmeros Corporation Common Stoc75

    18% of float sold short · 9.3 days to cover · +3% over 20 days

    SI 18%DTC 9.3$19.12+3% 20dHealthcare
  13. #13NAMSNewAmsterdam Pharma Company N.75

    20% of float sold short · 9.9 days to cover · -3% over 20 days

    SI 20%DTC 9.9$21.26-3% 20dHealthcare
  14. #14TWSTTwist Bioscience Corporation C75

    21% of float sold short · 8.9 days to cover · +20% over 20 days · options pricing in the 94th percentile (crowded)

    SI 21%DTC 8.9$152.05+20% 20dHealthcare
  15. #15IBRXImmunityBio, Inc. Common Stock74

    Short interest exceeds the float, but a going-concern warning and 41M new shares YTD make any pop a funding window.

    SI 110%DTC 15.9$9.91+28% 20dHealthcare

See the full ranked board

This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.

Open the live squeeze board →